"Roughly two dozen people led by the watchdog group Public Citizen gathered outside to express disgust over the skyrocketing cost of the auto-injector whose price has surged some 500 percent in recent years. Hundreds of thousands of people have signed on to petitions backing that view, and the group delivered the piles of paper to prove it... Several protesters, including retired state senator Jim Ferlo, criticized Mylan for paying CEO Heather Bresch nearly $19 million last year funded in part by collecting “super profits” on the EpiPen. “I consider this morally repugnant behavior by this CEO,” Mr. Ferlo said... Earlier, Mr. Ferlo and others called on Congress to enact reforms to ensure that expensive life-saving medications, including cancer and hepatitis drugs, can be afforded by everyone who needs them. “Health care is a human right,” said Ed Grystar, chair of the Western Pennsylvania Coalition for Single-Payer Healthcare."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
Showing posts with label choices between life-saving meds and basic human needs. Show all posts
Showing posts with label choices between life-saving meds and basic human needs. Show all posts
Wednesday, August 31, 2016
EpiPen furor brings protesters to Mylan’s headquarters; Pittsburgh Post-Gazette, 8/31/16
Patricia Sabatini, Pittsburgh Post-Gazette; EpiPen furor brings protesters to Mylan’s headquarters:
Subscribe to:
Posts (Atom)